Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits.
Alexandra Arias-MendozaJorge Arturo Ortega-HernandezDiego Araiza-GaraygordobilHector Gonzalez-PachecoMireya Martínez-GarcíaEnrique Hernández-LemusRodrigo Gopar-NietoTomás Tadeo Sandoval-AguilarDaniel Sierra-Lara MartinezSalvador Mendoza-GarcíaAlfredo Altamirano-CastilloJosé Luis Briseño-de-la-CruzMidori Alondra Ortega-HernándezLuis Alejandro Soliz-UrionaJorge Gaspar-HernándezPublished in: Therapeutics and clinical risk management (2023)
The findings of this study suggest that PI may be a more efficient treatment approach for STEMI in regions where access to pPCI is limited or where patient and system delays are expected.